We ligated the left anterior descending coronary artery for 1 or 2 h in 31 purebred beagles. We did not detect any changes in ,8-adrenergic receptor density or affinity when normal and ischemic zones were compared, either in the subendocardium or in the subepicardium. In the ischemic zones, there was a significant decline in all measures of adenylate cyclase activity, including activity mediated by the ,-adrenergic receptor. By contrast, after chronic fl-adrenergic blockade (1.5 mg/kg propranolol i.v. twice daily for 7 d), there was an increase in adenylate cyclase activity stimulated by (-)-isoproterenol relative to adenylate cyclase activity stimulated by guanyl-5'imidodiphosphate (GppNHp) in both normal and ischemic tissue, suggesting that one effect of chronic ,B blockade may be to enchance coupling between the stimulatory guanine nucleotide regulatory protein (Gs) and the fl-adrenergic receptor, despite a reduction in the number or function of Gs units. Chronic ,B blockade also led to up regulation of ,-adrenergic receptor density in subepicardial regions. After 20 min of reperfusion following 2 h of ischemia, adenylate cyclase activity tended to return to control levels, particularly in the subepicardium, where (-)-isoproterenol-stimulated adenylate cyclase activity was not different from normal myocardium. We conclude that chronic f-adrenergic blockade may have beneficial effects during prolonged episodes of myocardial ischemia by preserving signal transduction mediated by the ,-adrenergic receptor.
Introduction
The results of several large clinical trials have suggested that ,B-adrenergic blockade begun in the early stages of acute myocardial infarction may reduce mortality and morbidity (1) (2) (3) . Other clinical studies have shown no significant beneficial effect from the early use of 1 blockers in acute ischemia (4, 5) .
Large clinical trials also indicate that chronic 0-adrenergic blockade may reduce the incidence of recurrent myocardial infarction and sudden death in patients with previous infarction (6, 7) . One explanation for the use off,-adrenergic antagonists in early myocardial ischemia is that these agents prevent increases in adenylate cyclase activity, possibly as a result of blockade of an augmented number of 0-adrenergic receptors in the ischemic area.
There is considerable experimental evidence that f3-adrenergic receptors and their physiological responses may be altered during acute experimental myocardial ischemia. Mukherjee et al. (8) and Ohyanagi et al. (9) demonstrated in dogs that 1 h of proximal left anterior descending (LAD)I coronary artery ligation was associated with an increased density of jadrenergic receptors and that after 15 min of reflow, during which isoproterenol was administered, cAMP content rose (10) . After 1 h of LAD occlusion, Muntz et al., using an autoradiographic technique, noted a selective increase averaging 18% in 13-adrenergic receptor density over cardiac myocytes, but not over blood vessels in ischemic myocardium (1 1). Externalization of 3-adrenergic receptors during acute ischemia has been demonstrated by Maisel et al. ( 12) and this increase is potentially reversible (13) . Recently, Thandroyen et al. have shown in a cardiac myocyte cell culture system derived from neonatal rat ventricle that 2 h of hypoxia is associated with an increase of f3-adrenergic receptor number and a decrease in isoproterenol-stimulated adenylate cyclase activity (14) . By contrast, in the isolated nonblood-perfused working rabbit heart, 1 h of ischemia was associated with a decline in the maximal number of f-adrenergic binding sites (15) . Similar results have been reported in the rabbit after 30 min of ischemia (16) , and in embryonic chick and neonatal rat ventricular myocytes after 2 h of hypoxia ( 17, 18) . However, none of these studies have examined the effects of chronic f3-adrenergic blockade on myocardial blood flow, 3-adrenergic receptor density and affinity, and adenylate cyclase activity in acute ischemia. Further, no previous studies have attempted to determine whether there are any differences between subepicardium and subendocardium in these measurements. In this study, we sought to determine the effects of acute myocardial ischemia on 3-adrenergic receptors, signal transduction, and myocardial blood flow in the presence and in the absence of chronic f3-adrenergic blockade. We also studied the effects of reperfusion. left atrium were exposed through a small pericardial incision. After control microsphere measurement of myocardial blood flow, the LAD coronary artery was ligated near its origin to produce a large area of acute ischemia. At the time of ligation, 1-2 mg/kg lidocaine i.v. was given to reduce the incidence of ventricular arrhythmias. Blood flow measurements were repeated at the end of each study. In the dogs that had release of the LAD ligation, coronary blood flow was also measured at the end of 20 min of reperfusion.
At the end of each study, the area of central cyanosis distal to the coronary artery occlusion was demarcated in vivo and the heart was immediately removed and placed in iced 50 mM Tris buffer, pH 7.4, before sectioning. The left ventricular free wall was then divided into the previously demarcated ischemic zone anteriorly and a normal posterior zone opposite to the area of ischemia. Each of these zones was then divided transmurally into two equal regions as previously described (19) . These will be referred to as subendocardium and subepicardium throughout this manuscript. After mincing these fractions with scissors, aliquots were taken from each tissue sample, weighed and randomly assigned for measurement of myocardial blood flow, fl-adrenergic receptor binding studies, and assay of adenylate cyclase activity.
For the receptor and enzyme analyses, the minced tissue samples from both the ischemic and nonischemic subendocardial and subepicardial areas were homogenized in 0.25 M sucrose, 1 mM EDTA and 5 mM Tris-HCl, pH 7.4, and centrifuged at 270 g for 15 min. The supernatant was then pelleted at 41,300 g for 15 min and the pellet was washed two additional times in the same buffer and frozen in liquid nitrogen. The samples were stored at -70'C until analysis several weeks later. Previous studies showed that there is no loss of either receptor binding or adenylate cyclase activity under these circumstances compared with fresh tissue (19 (24) .
Adenylate cyclase activity. Adenylate cyclase activity was determined by a modification (Alvarez, R., and K. Littschwager, manuscript submitted for publication) of the method of Ramachandran (25) . The and the tube was heated to 100IC in a heating block for 3 min. 220 Al of 1.0 M Tris base was added and the samples were centrifuged at 2,500 rpm in a tabletop centrifuge for 10 min and then passed over a disposable column containing 1.5 g fresh, dry neutral alumina adsorption gel (AG7; Bio-Rad Laboratories, Richmond, CA). The column was eluted with 3.0 ml ofTris-HCl, pH 7.5 and the eluent was collected and counted in scintillation vials containing 12 ml of Beta-Phase (WestChem, San Diego, CA). Recovery of added 3H-cAMP was 90-95%. Maximum adenylate cyclase activity was assessed by measuring cAMP production in the presence of 10 mM NaF; membranes were also incubated separately with 0.1 mM guanyl-5'-imidodiphosphate (GppNHp). Because canine myocardial membranes respond poorly to (-)-isoproterenol stimulation alone at 1 AM, we also measured what we have called net (-)-isoproterenol stimulation (19) . This value is calculated by subtracting the GppNHp-stimulated activity from the sum of the latter plus 1 AM (-)-isoproterenol-stimulated activity. This is similar to the approach previously described by Marsh et al. (26) .
d blockade. In 10 dogs, 1.5 mg/kg propranolol was given twice daily for 1 wk through an indwelling venous catheter implanted in a neck vein under sterile conditions. The adequacy of 3 blockade was confirmed in each dog by the heart rate response to 0.3 Ag/kg of isoproterenol given in a rapid intravenous bolus. Before # blockade, the peak heart rate response to isoproterenol was an increase of 58.7±27.5 (SD) beats per minute (bpm) (range 28 to 122), whereas after ,3 blockade it was 6.6±13.8 bpm (range -12 to 28, P < 0.0005). Although isoproterenol has a short half life, to preclude any potential effects of this agent on the results, each dog was tested for its heart rate response the day before the experiment 2-3 h after dosing with propranolol. The experiment was carried out the next day at approximately the same time, after the morning dose of propranolol, and after the usual evening dose of the 3 blocker given the day before.
Statistical analysis. All data are expressed as mean±one SD. For comparisons, t test for paired or unpaired data was used as appropriate. Although our intention was to obtain data on myocardial blood flow, (3 receptors and adenylate cyclase activity from each sample, sufficient tissue was not always available for analysis. Sample numbers are indicated in the tables and figures for each analysis.
Results
(a) Myocardial blood flow (Table I ). All available blood flow data are shown in Table I . In control, normal subendocardium and subepicardium ischemia did not cause any significant alterations in myocardial blood flow. By contrast, after (3 blockade there was a significant decrease in blood flow in both normal subendocardium and subepicardium, possibly due to diminished metabolic demands. In the territory supplied by the LAD coronary artery, 1-2 h of ischemia resulted in marked declines in both subendocardial and subepicardial blood flow in control dogs by 80 and 73%, respectively, relative to baseline values. The decline of blood flow after ischemia during 3 blockade was similar (88% for subendocardium and 81% for subepicardium). Chronic (3-adrenergic blockade thus appeared to have no effect on the degree of myocardial ischemia produced by acute coronary artery ligation as measured by alterations in myocardial blood flow.
(b) f3-adrenergic receptors (Table II) . In the subendocardium, neither control nor /3-blocked dogs showed any increase in fl-adrenergic receptor density in the ischemic zone after LAD ligation. In the control dogs, receptor affinity for antagonist (Kd) also was unchanged. In the (-blocked dogs, there was a significant increase in Kd values both in the normal and ischemic tissues compared with the control dogs. In the subepicardium, there was a significant increase in f-receptor density in the normal f-blocked samples compared with the normal tissue in the control dogs, but no difference in the f-blocked ischemic zones compared with the non-fblocked ischemic areas. As in the subendocardium, Kd values in both the normal and ischemic f-blocked tissues were significantly increased compared with the samples from the control dogs.
(c) Adenylate cyclase activity (Table III) . After 1-2 h of subendocardial ischemia, there were significant declines in NaF-, GppNHp-, and net (-)-isoproterenol-stimulated adenylate cyclase activity when normal and ischemic tissues were compared. Similar results were noted in the f-blocked tissues. In the subepicardium, ischemia also resulted in significant decreases in all measures of adenylate cyclase activity in both control and f-blocked samples save for NaF-stimulated activity in the f-blocked subepicardium.
In both the subendocardium and the subepicardium, however, f blockade resulted in enhancement of (-)-isoproterenol-stimulated adenylate cyclase activity in both ischemic and nonischemic tissue compared with their respective control values. Further, the ratio of net (-)-isoproterenol-stimulated adenylate cyclase activity to GppNHp-stimulated enzyme activity was increased by chronic f-adrenergic blockade, both in normal and in ischemic tissue, suggesting that one effect of chronic : blockade may be to enhance coupling between the stimulatory guanine nucleotide regulatory protein and the fadrenergic receptor (Table IV) .
(d) Reperfusion. 20 min of reperfusion produced an increase in subendocardial blood flow of 2.45±1.8-fold over control levels. In the subepicardium this increase was 1.73±1.26-fold over control levels, indicating substantial reactive hyperemia. By contrast, in the nonischemic areas, the values for subendocardium and subepicardium were only (Table V) , with no change in Kd. Reperfusion had no significant effect on the decline in adenylate cyclase activity noted after 2 h of ischemia (Table VI). Similarly, in the subepicardium there were no significant changes in f3-adrenergic receptor density or affinity after 2 h of ischemia and 20 min of reperfusion (Table V) . As shown in Table VI , however, although adenylate cyclase activity stimulated by NaF and GppNHp was still reduced, the reduction in NaF-stimulated activity was considerably less than that observed in the subendocardium, whereas net (-)-isoproterenolstimulated activity was unchanged from control values. These observations indicate that reperfusion can produce a return toward control levels of adenylate cyclase activity mediated by the ,B-adrenergic receptor.
Discussion
Effects of acute ischemia. It is well known that severe acute myocardial ischemia leads to marked alterations in myocardial structure and function (27) . The generalized reduction in adenylate cyclase activity that we noted after severe ischemia is consistent with deterioration in myocardial membrane function, because this enzyme is a membrane bound molecular complex. That at least in the subepicardium adenylate cyclase activity tends to return rapidly to control levels after reperfusion suggests that the injury is reversible, despite its association with severe reductions of myocardial blood flow. Our observations regarding adenylate cyclase activity are consistent with those previously noted by others (14, (16) (17) (18) (28) (29) (30) (31) (32) . Hence, it is apparent that despite prior reports of increased 1-adrenergic receptor density (8-14, 30, 31) , adenylate cyclase activity transduced by the 13 receptor in acute ischemia is diminished. One potential consequence of massive catecholamine release accompanying acute ischemia is that it should actually lead to downregulation of the 13-adrenergic receptor (33) . The lack of change in adrenergic receptor density and affinity that we observed thus may actually represent relative upregulation in the face of well-documented increases in the local release of catecholamines in ischemic myocardium (34-36). Indeed, a number of reports have suggested that there is either no change or a decrease in 1-receptor density when normal and ischemic or hypoxic tissues are compared in crude membrane preparations from the dog (32), guinea pig (37), and rabbit (15, 16) or in intact embryonic chick or neonatal rat ventricular myocytes (17, 18) . The preservation of adrenergic receptor density and loss of isoproterenol-stimulated activity that we observed argue either for defective coupling between the ,B-adrenergic receptor and the adenylate cyclase complex, or a decrease or alteration in the number of functionally active stimulatory guanine nucleotide regulatory (Gs) units because both GppNHp-and NaF-stimulated activities were also reduced. In ischemic myocardial tissue, Devos et al. demonstrated that the concentration of isoproterenol required for half-maximal adenylate cyclase activation was identical in control and ischemic tissues and that the ischemic area demonstrated a marked increase in the number of low-affinity sites as measured by isoproterenol competition curves compared with control nonischemic myocardium (29 Effects of 13-adrenergic blockade. Previous studies of the 13-receptor after chronic 13-adrenergic blockade have yielded conflicting results, both increases in receptor density (38) (39) (40) (41) (42) (43) (44) or no change having been reported (45) (46) (47) (48) (49) (50) (52) . However, none of these studies examined 1-adrenergic receptor density or affinity in the presence of acute myocardial ischemia in 13-blocked preparations.
Moreover, none of these studies examined subendocardial versus subepicardial differences, nor did they take into account myocardial blood flow.
Our data, which are the first to examine the influence of chronic 1 blockade on 1 receptors and adenylate cyclase activity in experimental acute myocardial ischemia, indicate that 1 blockade has no significant effect on myocardial blood flow during acute ischemia, save for an increase in both subendocardial and subepicardial nonischemic areas after 1-2 h of coronary artery ligation. Our data also indicate that although there was a tendency for 13-adrenergic receptor density to increase after chronic 1-adrenergic blockade both in nonischemic and in ischemic tissue, this was significant only for nonischemic subepicardium. However, in all instances there was a highly significant three to fourfold increase in antagonist Kd. This observation, which is similar to reports by Aarons and Molinoff (40) and by Whyte et al. (43) , suggests that residual propranolol was present in the particulate preparation from ventricular tissue. This may be because propranolol exhibits considerable lipophilicity and likely persists in a given tissue even after the drug has been eliminated from the plasma (40) . Further evidence for adequate 13 blockade in our animal preparation was the virtual absence of an increase in heart rate after a challenge dose of 0.3 ,ug/kg of (-)-isoproterenol.
Consistent with the trend toward an increase in 1-adrenergic receptor density was the augmented (-)-isoproterenolstimulated adenylate cyclase activity in both subendocardial and subepicardial normal and ischemic areas when 13 blocked was compared with non-1-blocked tissue. A possible explanation for this relative preservation ofagonist-stimulated adenylate cyclase activity is suggested by the observations summarized in Table IV . Despite a reduction in GppNHp-stimulated adenylate cyclase activity during ischemia (Table III) , the ratio of (-)-isoproterenol-stimulated to GppNHp-stimulated activity was enhanced by 1-adrenergic blockade, both in normal and in ischemic tissue. In agreement with our observations, Devos et al. also observed a reduction in GppNHp-stimulated adenylate cyclase activity and suggested that prolonged ischemia causes a decrease in the number or conformation of functional stimulatory guanine nucleotide regulatory (Gs) units (29) . These data suggest that one mechanism of action of 13 Whether the results derived from our experimental model can help to explain the mechanism whereby chronic f3-adrenergic blockade reduces the incidence of recurrent infarction and sudden death in patients with previous infarction (6, 7) remains to be determined. It should be emphasized that the results of clinical studies during acute myocardial ischemia vary depending on the time of initiation of j3-blocker therapy (2, 4) . Because our studies were carried out during chronic f3 blockade, the results may be potentially applicable only to the situation in which acute ischemia occurs during the course of chronic fA-blocker treatment. As indicated earlier, our measurements of adenylate cyclase activity are consistent with those previously reported in mongrel dogs by others (27, 28) . However, we cannot exclude the possibility that the purebred beagle could have a different response, particularly with regard to alterations in ,3-adrenergic receptor density and externalization during ischemia, which has been demonstrated by others (8-14, 30, 31) . Reperfusion. There is considerable evidence that during relatively brief periods of ischemia the myocardial content of creatine phosphate and purine and pyrimidine nucleotide pools declines (59, 60) . With reperfusion, creatine phosphate levels tend to return rapidly to normal whereas the latter metabolites remain depressed for hours to days before returning to control levels (61, 62) . Prolonged periods of ischemia (1-2 h) such as those we induced can produce irreversible structural damage in the canine model (28, 63) . However, reperfusion after 2 h of occlusion appears to limit the size of myocardial necrosis and is associated with substantial functional recovery of jeopardized myocardium (64) . After short-term occlusion (15 min) and reperfusion for 3 h, severely depressed myocardium responds to f3-adrenergic stimulation as indicated by enhanced myocardial thickening (65) . In the anesthetized open chest dog model, coronary artery reperfusion at 1 or 3 h produced an immediate (but transient) improvement in regional myocardial function (66) .
Our data indicate that reperfusion for 20 min after 2 h of acute LAD occlusion is not associated with an increase in f3-adrenergic receptor density or change in affinity, either in the subendocardium or in the subepicardium. However, in the subepicardium the reduction in NaF-stimulated adenylate cyclase activity was less than in the subendocardium after reperfusion compared with control values. The reduction in net (-)-isoproterenol-stimulated adenylate cyclase activity, which persisted in the subendocardium, was abolished in the subepicardium. The f3-adrenergic receptor-adenylate cyclase complex thus appears to return to normal much more quickly in the subepicardium after short-term reperfusion after 2 h of ischemia. This phenomenon may provide at least a partial explanation for the ability of stunned myocardium to respond to positive inotropic stimuli after reperfusion (65) .
